BiotechTube

fluconazole

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Tinea Capitis

Conditions

Tinea Capitis

Trial Timeline

Nov 1, 2002 → Mar 1, 2003

NCT ID
NCT00645242

About fluconazole

fluconazole is a phase 3 stage product being developed by Pfizer for Tinea Capitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00645242. Target conditions include Tinea Capitis.

What happened to similar drugs?

3 of 10 similar drugs in Tinea Capitis were approved

Approved (3) Terminated (1) Active (6)
🔄Sertaconazole nitrate cream 2%Johnson & JohnsonPhase 3
❌Placebo cream + Ketoconazole 2% cream (formulation F012) (Nizoral) + Ketoconazole 2% cream (formulation F126)Johnson & JohnsonPhase 3
🔄Terbinafine hydrochloride (HCl) + GriseofulvinNovartisPhase 3
🔄Terbinafine + Terbinafine PlaceboNovartisPhase 3
🔄Terbinafine hydrochlorideNovartisPhase 3
🔄Econazole Nitrate Cream, 1% + PlaceboViatrisPhase 3
✅Luliconazole Cream 1% + Vehicle CreamBausch HealthApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (14)

NCT IDPhaseStatus
NCT00002077Pre-clinicalCompleted
NCT00002306Pre-clinicalCompleted
NCT00000627Pre-clinicalCompleted
NCT00002040Pre-clinicalCompleted
NCT00002010Pre-clinicalCompleted
NCT00002325Pre-clinicalCompleted
NCT00000744Pre-clinicalCompleted
NCT00002339Phase 3Completed
NCT00002038Pre-clinicalCompleted
NCT00002294Pre-clinicalCompleted
NCT00002076Pre-clinicalCompleted
NCT01806623Phase 3Completed
NCT01680458Pre-clinicalCompleted
NCT00645242Phase 3Completed

Competing Products

20 competing products in Tinea Capitis

See all competitors
ProductCompanyStageHype Score
Butenafine Hydrochloride 1% + Butenafine Hydrochloride 1% B + Butenafine Hydrochloride 1% + Vehicle A + Vehicle BSun PharmaceuticalPhase 1
21
Naftifine Hydrochloride Gel 2% + Naftin® Gel 2% + Placebo Topical GelSun PharmaceuticalPhase 1
29
Naftifine Hydrochloride Cream 2% + Naftin® (Naftifine Hydrochloride) Cream 2% + Placebo Topical CreamSun PharmaceuticalPhase 1
29
Butenafine Hydrochloride Cream, 1% + Lotrimin Ultra® + Butenafine VehicleSun PharmaceuticalPhase 1
29
Naftifine HCl Cream 1% + Naftin® (Naftifine HCl) Cream 1% + Placebo topical creamSun PharmaceuticalPhase 1
29
Ketoconazole Shampoo, 2% + Ketoconazole Shampoo, 2% (Reference Standard) + PlaceboSun PharmaceuticalPhase 1
29
TA103 + Placebo ControlSun PharmaceuticalPhase 1
29
Oxiconazole Nitrate Cream 1% + Oxiconazole Nitrate Cream 1% (Oxistat®) + PlaceboSun PharmaceuticalPhase 1
29
Butenafine cream 1% manufactured by Taro + Lotrimin Ultra (butenafine) 1% + Butenafine Vehicle manufactured by TaroSun PharmaceuticalPhase 1
29
Sertaconazole nitrate cream 2%Johnson & JohnsonPhase 3
36
Placebo cream + Ketoconazole 2% cream (formulation F012) (Nizoral) + Ketoconazole 2% cream (formulation F126)Johnson & JohnsonPhase 3
32
Terbinafine hydrochloride (HCl) + GriseofulvinNovartisPhase 3
40
Terbinafine + Terbinafine PlaceboNovartisPhase 3
40
Terbinafine hydrochlorideNovartisPhase 3
40
AN2718 + AN2718 + AN2718 + AN2718 + AN2718 + AN2718PfizerPhase 1
29
W0027 + PlaceboGSK plcPhase 1
29
Bifonazole spray once daily + Bifonazole spray twice daily + Placebo + Placebo + Lamisil OnceBayerPhase 2
32
Econazole Nitrate Cream, 1% + PlaceboViatrisPhase 3
37
LAS41003 + LAS189961 + LAS189962AlmirallPhase 2
29
Luliconazole Cream 1% + Vehicle CreamBausch HealthApproved
37